Cardiff Oncology, Inc. / Fundamental strength relative to industry (Mohanram G-Value) /

    The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.

    You are viewing the G-Value as of . Click to view the current G-Value instead.

    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7
    Return on assets (ROA) greater than industry median
    close -125.4% ≤ -51.2%
    Operating cash flow over total assets greater than industry median
    close -101.4% ≤ -86.3%
    Operating cash flow greater than net income
    check -$11.36M > -$14.05M
    Variance in ROA over the last 5 years less than industry median
    close 28.7% ≥ 10.5%
    Variance in year-over-year sales growth over the last 5 years less than industry median
    close 3.9% ≥ 1.9%
    R&D expenses over total assets greater than industry median
    check 85.3% > 42.1%
    Capex over total assets greater than industry median
    close -0.0% ≤ 0.0%

    G-Value history

    The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.

    1
    1
    2
    2
    3
    1
    1
    1
    2
    3
    3
    4
    3
    3
    4
    4
    5
    5
    5
    5
    3
    3
    4
    4
    4
    3
    3
    1
    2
    3
    1
    3
    3
    2
    2
    2
    5
    5
    4
    4
    3
    4
    4
    4
    4
    5
    5
    5
    5
    5
    5
    6
    5
    5
    5
    7

    Notifications